A case of castration-resistant prostate cancer with liver metastases achieved a complete response by docetaxel chemotherapy

Castration-resistant prostate cancer (CRPC) patients with liver metastases have an extremely poor prognosis. Herein, we report a rare patient who achieved a complete response by docetaxel chemotherapy for this aggressive disease. A 67-year-old Japanese male diagnosed with local prostate cancer [init...

Descripción completa

Detalles Bibliográficos
Autores principales: Shirotake, Suguru, Umezawa, Yuta, Okabe, Takashi, Kaneko, Go, Kanao, Kent, Nishimoto, Koshiro, Oyama, Masafumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215045/
https://www.ncbi.nlm.nih.gov/pubmed/32420190
http://dx.doi.org/10.21037/tau.2020.01.20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215045/
https://www.ncbi.nlm.nih.gov/pubmed/32420190
http://dx.doi.org/10.21037/tau.2020.01.20

Ejemplares similares